Bayer (BAYN) Stock Price, Fundamentals & Analysis
Price
50.02 EUR
+1.3%
Last trade: Sep 25, 2026, 05:35 PM GMT+2
Updated: Sep 27, 2026, 11:42 AM GMT+2
Price history
Over the past year BAYN traded between 26.06 EUR and 53.36 EUR, closing at 50.02 EUR on Sep 25, 2026.
Key statistics
| Market cap | 49.14B EUR |
|---|---|
| Forward P/E | 10.4 |
| EPS (TTM) | -1.76 EUR |
| Dividend yield | 0.22% |
| Annual dividend | 0.11 EUR |
| Ex-dividend date | Apr 27, 2026 |
| Payout ratio | 163% |
| 52-week range | 25.78 – 53.92 |
| 52-week change | 78.2% |
| Beta | 0.83 |
| Price / book | 1.66 |
| Revenue (TTM) | 45.38B EUR |
| Revenue growth (YoY) | 1.2% |
| Gross margin | 60.5% |
| Operating margin | 9.2% |
| Profit margin | -3.8% |
| Return on equity | -5.7% |
| Debt / equity | 129.4 |
| Volume | 2,465,179 |
| Average volume | 2,314,203 |
| Next earnings | Nov 3, 2026 |
| Exchange | XETRA |
Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 87,830
- Headquarters
- Leverkusen, Germany
- Website
- bayer.com
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing.
Overview
What BAYN does
Bayer (BAYN) is a life science company that operates across Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It works through three segments: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals segment focuses on prescription products for cardiology and women's health, as well as specialty therapeutics in oncology, hematology, and ophthalmology, plus diagnostic imaging and cell and gene therapy. Consumer Health covers over-the-counter medicines, nutritional supplements, and products for allergy, cough, cold, dermatology, pain, cardiovascular risk prevention, and digestive health. Crop Science offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management services. Bayer is listed on Xetra and is part of the DAX, alongside peers such as Fresenius (FRE), Siemens Healthineers (SHL), Fresenius Medical Care (FME), and Merck (MRK).
Key numbers explained
- Price: The current share price of 50,02 EUR is the latest trading value on the Xetra stocks market.
- P/E ratio: The forward P/E ratio of 10,4 divides the share price by expected future earnings, showing how much investors pay per euro of anticipated profit.
- Dividend yield: The dividend yield of 0,22% indicates the annual dividend payment as a percentage of the share price.
- Ex-dividend date: The exDividendDate of 27 apr. 2026 is the date after which new buyers are no longer entitled to the upcoming dividend.
- Payout ratio: A share of earnings paid out as dividends of 163% means the company distributed more in dividends than it earned over the trailing 12 months.
- Beta: A beta of 0,83 suggests the stock tends to move less than the overall market.
- 52-week range: The lowest and highest price in the last 52 weeks was 25,78 – 53,92 EUR, showing the trading range over the past year.
- Market cap: The marketCap of 49,14 mld. EUR reflects the total market value of all outstanding shares.
What to watch
Bayer's stock can be influenced by developments in its Pharmaceuticals, Consumer Health, and Crop Science segments. Investors often monitor pipeline updates, regulatory decisions, and product launches, especially in areas such as oncology and women's health. Crop Science performance can be affected by weather patterns, commodity prices, and agricultural demand. The company's debt-to-equity ratio of 129,4 and a returnOnEquity of -5,7% are factors that can shape how the market views its financial structure. Earnings releases, such as the one expected on 3 nov. 2026, and dividend policy decisions around the exDividendDate of 27 apr. 2026 are typical catalysts for price movement.
Latest news & filings
No recent headlines.
Frequently asked questions
Does BAYN pay a dividend?
Yes, Bayer pays a dividend. The dividend yield is 0,22%, and the exDividendDate is set for 27 apr. 2026.
What is the BAYN P/E ratio?
The forward P/E ratio is 10,4, based on expected earnings. The trailing 12-month earnings per share is -1,76 EUR.
Where can I buy BAYN?
BAYN trades on the Xetra market in Germany. You can buy it through any broker that offers access to Xetra-listed stocks.
What sector is Bayer in?
Bayer operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
How large is Bayer?
Bayer has a marketCap of 49,14 mld. EUR, 87.830 employees, and trailing 12-month revenue of 45,38 mld. EUR.
What is Bayer's 52-week price range?
Over the last 52 weeks, the price ranged from 25,78 EUR to 53,92 EUR, with a year-over-year price change of 78,2%.
Related
More on BAYN
Track BAYN in your portfolio
Hold BAYN at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free